3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
1911
Neoplasms
1531
Prostatic Neoplasms
753
Colorectal Neoplasms
714
Lung Neoplasms
583
Motor Activity
393
Head and Neck Neoplasms
328
Colonic Neoplasms
312
Uterine Cervical Neoplasms
300
Pain
248
Pancreatic Neoplasms
246
Anxiety Disorders
221
Rectal Neoplasms
214
Carcinoma, Hepatocellular
209
Carcinoma, Non-Small-Cell Lung
206
Fatigue
194
Stomach Neoplasms
192
Polycystic Ovary Syndrome
188
Ovarian Neoplasms
186
Precursor Cell Lymphoblastic Leukemia-Lymphoma
178
Brain Neoplasms
169
Depression
166
Urinary Bladder Neoplasms
165
Melanoma
163
Neoplasm Metastasis
162
Esophageal Neoplasms
140
Multiple Myeloma
138
Lymphoma
136
Lymphoma, Follicular
128
Obesity
127
Interventions
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Completed
×
Embolism and Thrombosis
×
Clear all
NCT04657120
2025-12-23
HYDRA
Leiden University Medical Center
Phase NA
Completed
698 enrolled